Target intelligence / Profile preview

Bacterial cell envelope phospholipids and phosphate-containing components

Molecular classification
Phospholipid, Glycolipid, Cell envelope component, Other
01

Overview

Bacterial cell envelope phospholipids and phosphate-containing components represent a diverse class of essential structural and functional molecules that define the boundary of the bacterial cell (NIH, Medical Microbiology). These include anionic phospholipids like phosphatidylglycerol and cardiolipin in the plasma membrane, as well as surface-exposed polymers such as lipopolysaccharides (LPS) in Gram-negative bacteria and teichoic acids in Gram-positive bacteria (Biology Ease). These components are vital for maintaining membrane integrity, regulating ion homeostasis, and anchoring proteins involved in cell wall synthesis and division (PMC, Progress in Lipid Research). Because bacterial membranes are significantly more anionic than the zwitterionic membranes of mammalian cells, they serve as selective targets for several classes of antibiotics, including polymyxins and lipopeptides like daptomycin (PubMed). Drugs interacting with these targets typically cause rapid membrane depolarization or physical disruption, leading to the leakage of intracellular contents and cell death, which is particularly valuable for treating multidrug-resistant infections (PMC, Journal of Biological Chemistry).

Other names
Bacterial cell membraneBacterial anionic phospholipidsBacterial cell wall phospholipidsBacterial phosphate-containing surface componentsAnionic membrane lipidsBacterial cell envelopeBacterial cell membrane and cell wall phospholipids/phosphate-containing surface components
02

Mechanism of action

Drugs targeting these components typically act by binding to anionic headgroups of phospholipids or phosphate moieties in lipopolysaccharides and teichoic acids, leading to membrane permeabilization, pore formation, or inhibition of cell wall synthesis precursors like Lipid II.

03

Biological functions

Structural integritySelective permeabilityIon homeostasisCell wall organizationEnergy transductionImmune responseCell death
04

Disease associations

Infection
05

Safety considerations

NephrotoxicityNeurotoxicityMyopathyRhabdomyolysisHemolysisTherapeutic index limitations
06

Interacting drugs

Polymyxin B

10 more in the full profile.

07

Biomarkers

Minimum inhibitory concentration (MIC)Membrane depolarizationCreatine phosphokinase (CPK)Serum creatinineATP leakage

Beyond the preview

Go deeper on Bacterial cell envelope phospholipids and phosphate-containing components.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial cell envelope phospholipids and phosphate-containing components.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call